| Die meistzitierten Artikel | Die meistzitierten Reviews | Die meistzitierten Köpfe |
Bild der meistzitierten Köpfe |
||
Die meistzitierten Artikel |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Druker BJ, ..., Buchdunger E, Ford JM, ..., Capdeville R, ..., Sawyers CL | Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. NEW ENGL. J. OF MEDICINE 344 (14): 1031-1037 APR 5 2001 | 1123 |
| 2. | Slamon DJ, ..., Eiermann W, ..., Norton L | Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. NEW ENGLAND JOURNAL OF MEDICINE 344 (11): 783-792 MAR 15 2001 | 985 |
| 3. | Druker BJ, ..., Reese SF, Ford JM, Capdeville R, Talpaz M | Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. NEW ENGL. J. OF MEDICINE 344 (14): 1038-1042 APR 5 2001 | 802 |
| 4. | Muller A, ..., Wagner SN, ..., Zlotnik A | Involvement of chemokine receptors in breast cancer metastasis. NATURE 410 (6824): 50-56 MAR 1 2001 | 579 |
| 5. | Kantarjian H,..., Hochhaus A, ..., Niederwieser D, ..., Capdeville R, Zoellner U, ..., Druker B | Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. NEW ENGL. J. OF MEDICINE 346 (9): 645-652 FEB 28 2002 | 498 |
| 6. | Joensuu H, ..., Capdeville R, Dimitrijevic S, ..., Demetri GD | Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. NEW ENGLAND JOURNAL OF MEDICINE 344 (14): 1052-1056 APR 5 2001 | 473 |
| 7. | Demetri GD, ..., Silberman SL, Capdeville R, Kiese B, ..., Dimitrijevic S, ..., Joensuu H | Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. NEW ENGLAND JOURNAL OF MEDICINE 347 (7): 472-480 AUG 15 2002 | 434 |
| 8. | McSweeney PA, Niederwieser D, ..., Hegenbart U, ..., Storb RF | Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. BLOOD 97 (11): 3390-3400 JUN 1 2001 | 433 |
| 9. | Khan J, ..., Westermann F, Berthold F, Schwab M,..., Meltzer PS | Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. NATURE MEDICINE 7 (6): 673-679 JUN 2001 | 316 |
| 10. | Braun S, Pantel K, Müller P, Janni W, Hepp F, Kentenich CRM, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmüller G, Schlimok G | Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. NEW ENGL. J. OF MEDICINE 342 (8): 525-533 FEB 24 2000 | 313 |
Die meistzitierten Reviews |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Krammer PH | CD95‘s deadly mission in the immune system. NATURE 407 (6805): 789-795 OCT 12 2000 | 539 |
| 2. | Brazil DP, Hemmings BA | Ten years of protein kinase B signalling: a hard Akt to follow. TRENDS IN BIOCHEMICAL SCIENCES 26 (11): 657-664 NOV 2001 | 308 |
| 3. | zur Hausen H | Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J. OF THE NAT. CANC. INST. 92 (9): 690-698 MAY 3 2000 | 247 |
Die meistzitierten Köpfe |
||||
| Rang | Name | Ort | Zitierungen | Artikel |
| 1 | Renaud Capdeville | Novartis Onkologie Basel | 4184 | 19 |
| 2 | Eva B. Bröcker | Hautklinik Uni Würzburg | 2563 | 82 |
| 3 | Elisabeth Buchdunger | Novartis Onkologie Basel | 2290 | 15 |
| 4 | Gerold Schuler | Hautklinik Uni Erlangen | 2266 | 40 |
| 5 | Peter H. Krammer | DKFZ Heidelberg | 1788 | 47 |
| 6 | Jürgen Knop | Hautklinik Uni Mainz | 1689 | 34 |
| 7 | Andreas Hochhaus | Hämatol. & Onkol. Klinikum Mannheim | 1661 | 23 |
| 8 | Guido Sauter | Pathol. Uni Basel | 1632 | 41 |
| 9 | Martin Lipp | Tumor- & Immungenet. MDC Berlin | 1614 | 30 |
| 10 | Sasa Dimitrijevic | Novartis Onkologie Basel | 1519 | 6 |
| 11 | Alois Gratwohl | Hämatol. & Onkol. Kantonsspital Uni Basel | 1517 | 46 |
| 12 | Erwin F. Wagner | Forschungsinst. Mol. Pathol. (IMP) Wien | 1514 | 36 |
| 13 | Alexander H Enk | Hautklinik Uni Mainz (seit 2004 Uni Heidelberg) | 1508 | 24 |
| 14 | Volker Diehl | Hämatol. & Onkol. Med. Klinik Uni Köln | 1429 | 100 |
| 15 | Jeanette M. Wood | Novartis Onkologie Basel | 1356 | 24 |
| 16 | Helmut Jonuleit | Hautklinik Uni Mainz | 1336 | 13 |
| 17 | Brian A. Hemmings | Friedrich-Miescher-Inst. (FMI) Basel | 1319 | 26 |
| 18 | Dietger Niederwieser | Hämatol. & Onkol. Med. Klinik Uni Leipzig | 1293 | 30 |
| 19 | Michael Weller | Neurol. Klinik Uni Tübingen | 1284 | 76 |
| 20 | Wolfgang Hiddemann | Hämatol. & Onkol. Med. Klinik Uni München | 1244 | 80 |
| 21 | Lothar Kanz | Hämatol. & Onkol. Med. Klinik Uni Tübingen | 1233 | 64 |
| 22 | Peter Lichter | DKFZ Heidelberg | 1229 | 48 |
| 23 | Hans-K. Müller-Hermelink | Pathol. Uni Würzburg | 1228 | 47 |
| 24 | Oliver G. Ottmann | Hämatol. & Onkol. Med. Klinik Uni Frankfurt | 1202 | 29 |
| 25 | Michael J. Mihatsch | Pathol. Uni Basel | 1162 | 37 |
| 26 | Klaus Schulze-Osthoff | Institut für molekulare Medizin, Universität Düsseldorf | 1151 | 38 |
| 27 | Fritz Jänicke | Klinik für Frauenheilkunde Eppendorf Uni Hamburg | 1118 | 21 |
| 28 | Walter Birchmeier | MDC Berlin | 1102 | 18 |
| 29 | Wolfgang Eiermann | Frauenklinik vom Roten Kreuz München | 1100 | 6 |
| 30 | Henning Walczak | DKFZ Heidelberg (Apogenix Biotechnologie AG) | 1089 | 22 |
| 31 | Manfred Stolte | Pathol. Klinikum Bayreuth | 1079 | 65 |
| 32 | Hartmut Döhner | Hämatol. & Onkol. Med. Klinik Uni Ulm | 1070 | 38 |
| 33 | Wolfgang E. Berdel | Hämatol. & Onkol. Med. Klinik Uni Münster | 1057 | 40 |
| 34 | Bernd Dörken | Hämatol & Onkol. HU Berlin (Charité) / MDC Berlin | 1053 | 49 |
| 35 | Dieter Hoelzer | Hämatol. & Onkol. Med. Klinik Uni Frankfurt | 1032 | 86 |
| 36 | Hermann J. Gröne | DKFZ Heidelberg | 1018 | 55 |
| 37 | Harald Stein | Pathol. FU Berlin (Klinikum Benjamin Franklin) | 1004 | 43 |
| 38 | Claudia Schoch | Hämatol. & Onkol. Klin. Großhadern Uni München | 969 | 96 |
| 39 | Christian Peschel | Hämatol & Onkol. TU München (Klin. r. d. Isar) | 957 | 31 |
| 40 | Holger Moch | Klin. Pathol. Uni Zürich (bis 2003 Basel) | 956 | 31 |
| 41 | Eckhard Thiel | Hämatol & Onkol. FU Berlin (Klinikum Ben. Franklin) | 953 | 41 |
| 42 | Klaus-Michael Debatin | Universitätskinderklinik, Ulm | 941 | 37 |
| 43 | Alexander Knuth | Nordwestkrankenhaus Frankfurt (seit 2003 Zürich) | 932 | 18 |
| 44 | Gerhard Ehninger | Hämatol & Onkol. Med. Klinik TU Dresden | 902 | 68 |
| 45 | Manfred Schmitt | Frauenklinik TU München | 899 | 34 |
| 46 | Dieter Keppler | DKFZ Heidelberg | 898 | 22 |
| 47 | Thomas Kirchner | Pathol. Uni Erlangen | 895 | 48 |
| 48 | Hans G. Beger | Chirurg. Klinik Uni Ulm | 851 | 65 |
| 49 | Martin Schrappe | Päd. Hämatol. & Onkol. Kinderklinik MH Hannover | 842 | 32 |
| 50 | Klaus Pantel | Tumorbiol. Klinikum Eppendorf Uni Hamburg | 828 | 17 |
| 51 | Manfred Dietel | Pathol. HU Berlin (Klinikum Charité) | 820 | 43 |
